Department of Urology, Section of Andrology, Tulane University School of Medicine, New Orleans, LA, USA.
Int J Impot Res. 2024 Jun;36(4):333-338. doi: 10.1038/s41443-023-00768-4. Epub 2023 Sep 26.
Though early research suggested that thyroid hormones were not involved with the testes, male spermatogenesis, or erectile function, investigations on this topic over the past few decades have increased and shed new light. A literature review of studies conducted between 1963 and 2022 regarding male sexual dysfunction (SD) and thyroid disorders was performed to define the diagnostic consideration, pathophysiology, and management of SD secondary to thyroid dysregulation. This article provides evidence and interpretation of prior clinical and preclinical studies and contextualizes these studies for clinical practice. Clinical manifestations of SDs included erectile and ejaculatory dysfunction, impaired spermatogenesis, and disruption of the hypothalamic-pituitary-gonadal axis. Our aim of this communication was to perform a literature review detailing the impact of thyroid disorders on male SD. We hope to provide a framework for practicing urologists, endocrinologists, or general practitioners when evaluating patients with concurrent thyroid and male SD. It is important to recognize that thyroid disorders can be an important part of the pathophysiology of male SD in patients. Future research studies are needed to further elucidate the mechanisms involved.
尽管早期的研究表明甲状腺激素与睾丸、男性精子发生或勃起功能无关,但过去几十年对这一主题的研究增加了,并提供了新的见解。对 1963 年至 2022 年间关于男性性功能障碍 (SD) 和甲状腺疾病的研究进行了文献回顾,以确定甲状腺功能失调导致 SD 的诊断考虑因素、病理生理学和管理。本文提供了先前临床和临床前研究的证据和解释,并为临床实践提供了这些研究的背景。SD 的临床表现包括勃起和射精功能障碍、精子发生受损以及下丘脑-垂体-性腺轴的破坏。我们撰写这篇文章的目的是对详细描述甲状腺疾病对男性 SD 的影响的文献进行综述。我们希望为评估同时患有甲状腺和男性 SD 的患者的泌尿科医生、内分泌科医生或全科医生提供一个框架。重要的是要认识到,甲状腺疾病可能是男性 SD 患者病理生理学的重要组成部分。需要进一步的研究来阐明涉及的机制。